TAISF Stock: Taisho Pharmaceutical Holdings Co., Ltd. Stock Price, Analysis & Insights
Get live TAISF stock price $59.00, comprehensive Taisho Pharmaceutical Holdings Co., Ltd. stock analysis, charts, news, and expert forecast. Real-time TAISF stock data and investment insights.
Loading chart data...
Taisho Pharmaceutical Holdings Co., Ltd. (TAISF) Overview
Taisho Pharmaceutical Holdings Co., Ltd. (TAISF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, TAISF trades at $59.00 with a market capitalization of 118 . Over the past 52 weeks, TAISF has traded between $38.00 and $60.00 , with the current price positioned at approximately 9...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 118
- Current price: $59.00
- 52-week range: $38.00 - $60.00
- P/E ratio: 86.76
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Taisho Pharmaceutical Holdings Co., Ltd., headquartered in Tokyo, Japan, is a long-established global pharmaceutical company, founded in 1912. The company and its subsidiaries are comprehensively involved in the research, development, manufacturing, ...
Company Information
- CEO
- Akira Uehara
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 8784
Contact Information
- Address
- 3-24-1 Takada
- Country
- JP
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 86.8)
✓ Lower volatility stock (Beta: 0.50) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Taisho Pharmaceutical Holdings Co., Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Taisho Pharmaceutical Holdings Co., Ltd.
- ⚠Investors should consider how Taisho Pharmaceutical Holdings Co., Ltd. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 86.8) requires strong growth to justify
Market Cap
118
P/E Ratio (TTM)
86.76
Beta
0.50
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare TAISF with peer companies:
- Price
- $0.00
- Market cap
- 122
- Price
- $0.00
- Market cap
- 26
- Price
- $0.00
- Market cap
- 1.77K
- Price
- $0.00
- Market cap
- 44
- Price
- $0.00
- Market cap
- 117
- Price
- $0.00
- Market cap
- 132
- Price
- $0.00
- Market cap
- 220
- Price
- $0.00
- Market cap
- 101
- Price
- $0.00
- Market cap
- 97
- Price
- $0.00
- Market cap
- 120
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.